Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Lyme disease-a tick-borne spirochetosis?.Science. 1982; 216: 1317-1319
- The spirochetal etiology of Lyme disease.N Engl J Med. 1983; 308: 733-740
- European Borrelia burgdorferi isolated from humans and ticks culture conditions and antibiotic susceptibility.Zentralbl Bakteriol Mikrobiol Hyg A. 1986; 263: 112-118
- Cultivation of Borrelia hermsi.Science. 1971; 173: 443-444
- Improving the yield of blood cultures for patients with early Lyme disease.J Clin Microbiol. 1998; 36: 296-298
- Yield of large-volume blood cultures in patients with early Lyme disease.J Infect Dis. 2001; 184: 1070-1072
- Diagnosis of Lyme borreliosis.Clin Microbiol Rev. 2005; 18: 484-509
- Gene regulation in Borrelia burgdorferi.Annu Rev Microbiol. 2011; 65: 479-499
- Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes.Nat Rev Microbiol. 2012; 10: 87-99
- Effect of tick removal on transmission of Borrelia burgdorferi and Ehrlichia phagocytophila by Ixodes scapularis nymphs.J Infect Dis. 2001; 183: 773-778
- Innate immunity networks during infection with Borrelia burgdorferi.Crit Rev Microbiol. 2014; ([Epub ahead of print])
- Brief communication: hematogenous dissemination in early Lyme disease.Ann Intern Med. 2005; 142: 751-755
- Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans.Ann Intern Med. 2002; 136: 421-428
- Lyme disease.N Engl J Med. 2014; 371: 684
- Erythema migrans.Med Clin North Am. 2002; 86: 239-260
- Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans.J Clin Microbiol. 1996; 34: 1-9
- BBK07 immunodominant peptides as serodiagnostic markers of Lyme disease.Clin Vaccine Immunol. 2011; 18: 406-413
- Identification of OppA2 linear epitopes as serodiagnostic markers for Lyme disease.Clin Vaccine Immunol. 2014; 21: 704-711
Centers for Disease Control and Prevention. Proceedings of the First National Conference on Lyme Disease Testing, Dearborn, Michigan, 1990. Centers for Disease Control and Food and Drug Administration, Washington, DC, November 1–2, 1990.
- Performance of 45 laboratories participating in a proficiency testing program for Lyme disease serology.JAMA. 1992; 268: 891-895
- Improved serodiagnostic testing for Lyme disease: results of a multicenter serologic evaluation.Emerg Infect Dis. 1996; 2: 136-140
- Isolation of antigenic components from the Lyme disease spirochete: their role in early diagnosis.J Infect Dis. 1987; 155: 756-765
- Comparison of Western blot and enzyme-linked immunosorbent assay for diagnosis of Lyme borreliosis.Eur J Clin Microbiol Infect Dis. 1989; 8: 871-877
- Serodiagnosis in early Lyme disease.J Clin Microbiol. 1993; 31: 3090-3095
- Western blotting in the serodiagnosis of Lyme disease.J Infect Dis. 1993; 167: 392-400
- Immunoblot interpretation criteria for serodiagnosis of early Lyme disease.J Clin Microbiol. 1995; 33: 419-427
- Serodiagnosis of Lyme disease: accuracy of a two-step approach using a flagella-based ELISA and immunoblotting.J Infect Dis. 1996; 174: 346-353
Centers for Disease Control and Prevention. Proceedings of the Second National Conference on Serological Diagnosis of Lyme Disease, Dearborn, Michigan, 1995. Association of State and Territorial Public Health Laboratory Directors and the Centers for Disease Control and Prevention, Washington, October 27–29, 1994.
- Recommendations for test performance and interpretation from the second national conference on serologic diagnosis of Lyme disease.MMWR Morb Mortal Wkly Rep. 1995; 44: 590-591
- Tick-transmitted disease survey TTD-B.College of American Pathologist, Northfield (IL)2009
- The emergence of Lyme disease.J Clin Invest. 2004; 113: 1093-1101
- Clinical practice. Lyme disease.N Engl J Med. 2014; 370: 1724-1731
- Prospective study of serologic tests for Lyme disease.Clin Infect Dis. 2008; 47: 188-195
- Effect of Borrelia burgdorferi genotype on the sensitivity of C6 and 2-tier testing in North American patients with culture-confirmed Lyme disease.Clin Infect Dis. 2008; 47: 910-914
- Impact of clinical variables on Borrelia burgdorferi-specific antibody seropositivity in acute-phase sera from patients in North America with culture-confirmed early Lyme disease.Clin Vaccine Immunol. 2008; 15: 1519-1522
- 2-tiered antibody testing for early and late Lyme disease using only an immunoglobulin G blot with the addition of a VlsE band as the second-tier test.Clin Infect Dis. 2010; 50: 20-26
- Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay.Clin Infect Dis. 2011; 53: 541-547
- Performance of United States serologic assays in the diagnosis of Lyme borreliosis acquired in Europe.Clin Infect Dis. 2013; 57: 333-340
- Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease.Diagn Microbiol Infect Dis. 2013; 75: 9-15
- Lyme borreliosis.Lancet. 1998; 352: 557-565
- Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group.N Engl J Med. 1998; 339: 209-215
- Treatment of early Lyme disease.Am J Med. 1992; 92: 396-403
- Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates.J Infect Dis. 2003; 187: 1187-1199
- Case records of the Massachusetts General Hospital. Case 11-2007. A 59-year-old man with neck pain, weakness in the arms, and cranial-nerve palsies.N Engl J Med. 2007; 356: 1561-1570
- Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes.Cell. 1997; 89: 275-285
- Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE.J Clin Microbiol. 1999; 37: 3990-3996
- Comparative cost-effectiveness of two-tiered testing strategies for serodiagnosis of Lyme disease with noncutaneous manifestations.J Clin Microbiol. 2013; 51: 4045-4049
- Collection and characterization of samples for establishment of a serum repository for Lyme disease diagnostic test development and evaluation.J Clin Microbiol. 2014; 52: 3755-3762
- Laboratory evaluation in the diagnosis of Lyme disease.Ann Intern Med. 1997; 127: 1109-1123
- Poor positive predictive value of Lyme disease serologic testing in an area of low disease incidence.Clin Infect Dis. 2015; ([Epub ahead of print])
- Geographic variation in the relationship between human Lyme disease incidence and density of infected host-seeking Ixodes scapularis nymphs in the Eastern United States.Am J Trop Med Hyg. 2012; 86: 1062-1071
- Lyme borreliosis in Bell's palsy. Long Island Neuroborreliosis Collaborative Study Group.Neurology. 1992; 42: 1268-1270
- Microbiological diagnosis in Lyme borreliosis.Int J Med Microbiol. 2002; 291: 114-119
- Utility of serodiagnostics designed for use in the United States for detection of Lyme borreliosis acquired in Europe and vice versa.Med Microbiol Immunol. 2014; 203: 65-71
Article info
Identification
Copyright
Published by Elsevier Inc.
